Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription Articles published in Dis Esophagus Retrieve available abstracts of 207 articles: HTML format

Single Articles

September 2026
1. ABE T, Higaki E, Hosoi T, Inada K, et al
   Oncological outcomes and recurrence patterns after robot-assisted versus video-assisted esophagectomy for cT3br/cT4b esophageal cancer.
   Dis Esophagus. 2026;39:doag095.
   PubMed     Abstract available
   
   
   July 2026
2. HIMEMATSU H, Fukushima T, Matsumori K, Ikeda T, et al
   Predictors of postoperative health-related quality of life in patients with esophageal cancer: a scoping review.
   Dis Esophagus. 2026;39:doag071.
   PubMed     Abstract available
   
   
   
3. SANDERS ME, Lammes FE, Kalash S, van der Horst S, et al
   Cervical lymph node metastases in thoracic esophageal cancer: a systematic review.
   Dis Esophagus. 2026;39:doag068.
   PubMed     Abstract available
   
   
   
4. SAKANAKA K, Kato K, Machida R, Ito Y, et al
   Squamous cell carcinoma antigen and carcinoembryonic antigen monitoring during post-definitive chemoradiotherapy surveillance for esophageal squamous cell carcinoma: JCOG2106A.
   Dis Esophagus. 2026;39:doag072.
   PubMed     Abstract available
   
   
   
5. NOMURA M, Bronzwaer SFC, Kroese TE, van Rossum PSN, et al
   Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes.
   Dis Esophagus. 2026;39:doag078.
   PubMed     Abstract available
   
   
   
6. HANNA NM, Huo B, Mir ZM, Agzarian J, et al
   Endoscopic resection versus esophagectomy for T1bN0M0 esophageal cancer: a systematic review and meta-analysis.
   Dis Esophagus. 2026;39:doag083.
   PubMed     Abstract available
   
   
   
7. SHAH M, Noronha V, Menon N, Niyogi D, et al
   Lessons learned from the use of capecitabine-based triplet neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
   Dis Esophagus. 2026;39:doag082.
   PubMed     Abstract available
   
   
   
8. SILVER A, Habib H, Giet L, Gossage J, et al
   Crural hiatoplasty with left liver buttress reinforcement for paraconduit hiatus hernia repair: early lessons from a single-center case series.
   Dis Esophagus. 2026;39:doag091.
   PubMed     Abstract available
   
   
   
9. STUART SK, Geerts JFM, Klarenbeek BR, Hutteman M, et al
   Reasons for hospital readmissions after esophagectomy for cancer.
   Dis Esophagus. 2026;39:doag092.
   PubMed     Abstract available
   
   
   May 2026
10. HOLMEN A, Murad F, Nilsson K, Rouvelas I, et al
    Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trial.
    Dis Esophagus. 2026;39:doag047.
    PubMed     Abstract available
    
    
    
11. TROTTENBERG T, Hegazy M, Astany S, Sedighi S, et al
    Esophageal Cancer Patient Network: a scalable platform for integrating patient voices across the research lifecycle.
    Dis Esophagus. 2026;39:doag046.
    PubMed     Abstract available
    
    
    
12. WISSING RO, Matthee E, Baranov NS, Ubels S, et al
    Are age, comorbidity, and frailty associated with complications after minimally invasive esophagectomy? A multicenter cohort study.
    Dis Esophagus. 2026;39:doag039.
    PubMed     Abstract available
    
    
    
13. ZEYARA A, Kuiper GM, Vanstraelen S, Ruurda JP, et al
    Surgical approach and oncological outcomes in Siewert type II junctional tumors.
    Dis Esophagus. 2026;39:doag049.
    PubMed     Abstract available
    
    
    
14. CHAN MM, Roy AC, Watson DI, Bright T, et al
    Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas.
    Dis Esophagus. 2026;39:doag048.
    PubMed     Abstract available
    
    
    
15. ALHAYO S, Seabourne E, Hall L, Shepherdson M, et al
    Real-world outcomes of FLOT versus Chemoradiotherapy for Esophageal, Type I and II Junctional Tumors: A Bi-Center International Study.
    Dis Esophagus. 2026;39:doag052.
    PubMed     Abstract available
    
    
    
16. ZHANG G, Gao S, Yin Q, Zhou S, et al
    Preserving the right gastric artery reduces early anastomotic stenosis after McKeown minimally invasive esophagectomy: a randomized controlled trial.
    Dis Esophagus. 2026;39:doag050.
    PubMed     Abstract available
    
    
    
17. MARTINO A, Petri R, Uzzau A, Del Favero C, et al
    VERDEDT 1.0: five years single-center experience with real-time indocyanine green fluorescence imaging of the thoracic duct during minimally invasive esophagectomy.
    Dis Esophagus. 2026;39:doag057.
    PubMed     Abstract available
    
    
    
18. LAKUNINA S, Kamarajah SK, Hedberg J, Isik A, et al
    The effect of complications on the esophageal cancer surgeon: an international survey exploring the impact these have on professional and personal life.
    Dis Esophagus. 2026;39:doag056.
    PubMed     Abstract available
    
    
    
19. FOUAD M, Sourial K, Ibraheim S
    Impact of omental flap reinforcement on anastomotic leak after esophagectomy: updated evidence incorporating minimally invasive and high-volume contemporary series.
    Dis Esophagus. 2026;39:doag061.
    PubMed     Abstract available
    
    
    
20. ABE T, An B, Higaki E, Hosoi T, et al
    Lessons learned from routine thoracic duct visualization using high-fat ice cream during esophagectomy: insights from long-term clinical practice.
    Dis Esophagus. 2026;39:doag060.
    PubMed     Abstract available
    
    
    
21. CAMMAROTA A, Puccini A, Jones CM, van Rossum PSN, et al
    Circulating tumour DNA in oligometastatic oesophago-gastric cancers: applications, challenges, and future directions.
    Dis Esophagus. 2026;39:doag059.
    PubMed     Abstract available
    
    
    
22. LEONARD D, Thota PN, Sehgal V
    Screening for Barrett's esophagus and esophageal adenocarcinoma: recent advances and next steps.
    Dis Esophagus. 2026;39:doag067.
    PubMed     Abstract available
    
    
    
23. WU H, Han Z, Wu J, Zhang Y, et al
    CD39 and PD-L1 co-expression may serve as potential indicators for evaluating the efficacy of neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
    Dis Esophagus. 2026;39:doag063.
    PubMed     Abstract available
    
    
    
24. YANG Y, Fan X, Hong H, Ding J, et al
    Diagnostic performance of postoperative endoscopy versus water-soluble esophagram in detecting anastomotic leak after esophagectomy.
    Dis Esophagus. 2026;39:doag062.
    PubMed     Abstract available
    
    
    March 2026
25. RAYNER CJ, Paine H, Luangsomboon A, McGuire A, et al
    Robotic-Assisted Ivor Lewis Esophagectomy (RAILE): a comparative analysis of a single unit, consecutive series of Open, Hybrid, and Robotic approaches.
    Dis Esophagus. 2026;39:doag016.
    PubMed     Abstract available
    
    
    
26. PROVOOST N, Zellenrath PA, Plompen EPC, Oudijk L, et al
    Lessons learned: the importance of timely recognition of verrucous squamous cell carcinoma in the esophagus.
    Dis Esophagus. 2026;39:doag021.
    PubMed     Abstract available
    
    
    
27. KOHN GP, Litle V, Eliya Y, Leng S, et al
    ISDE guidelines on the management of cT2N0 esophageal cancer.
    Dis Esophagus. 2026;39:doag019.
    PubMed     Abstract available
    
    
    
28. GARBARINO GM, Pansa A, Giorgi L, De Martino R, et al
    Balancing innovation and risks in esophageal surgery: lessons from the hybrid Ivor-Lewis technique.
    Dis Esophagus. 2026;39:doag020.
    PubMed     Abstract available
    
    
    
29. ABDEL FATTAH AR, Mahdy K, Abdelhamid A, Nanthakumaran S, et al
    Prognostic factors for paraconduit hernia in adult patients post-esophagectomy for cancer: a systematic review.
    Dis Esophagus. 2026;39:doag017.
    PubMed     Abstract available
    
    
    
30. SPATARO J, Fuchs M, Zfass A
    Clinical tips to optimize liquid nitrogen spray cryotherapy in esophageal malignancy.
    Dis Esophagus. 2026;39:doag024.
    PubMed     Abstract available
    
    
    
31. TSUNODA S, Nishigori T, Okumura S, Hisamori S, et al
    Minimally invasive salvage esophagectomy following definitive chemoradiotherapy for esophageal cancer.
    Dis Esophagus. 2026;39:doag026.
    PubMed     Abstract available
    
    
    
32. DE OLIVEIRA JF, Martins BC, Moura RN, de Paulo GA, et al
    Randomized trial of intralesional steroid injection versus oral prednisolone for preventing esophageal stricture after extensive endoscopic submucosal dissection.
    Dis Esophagus. 2026;39:doag027.
    PubMed     Abstract available
    
    
    
33. ZALEWSKI A, Lin DC, Lo AA, Yang GY, et al
    Increased prevalence of esophageal squamous cell papilloma in eosinophilic esophagitis: incidental finding or disease related consequence?
    Dis Esophagus. 2026;39:doag022.
    PubMed     Abstract available
    
    
    
34. ISHIYAMA K, Nozaki R, Kakuta R, Igaue S, et al
    Short- and long-term outcomes of conversion minimally invasive esophagectomy versus open approach following induction therapy in cT4b esophageal cancer.
    Dis Esophagus. 2026;39:doag025.
    PubMed     Abstract available
    
    
    
35. ZHOU MJ, Triadafilopoulos G
    Potassium competitive acid blockers in Barrett's esophagus: lessons from gastro-esophageal reflux disease and future directions.
    Dis Esophagus. 2026;39:doag033.
    PubMed     Abstract available
    
    
    
36. KUNG CH, Vissapragada R, Schloithe A, Bright T, et al
    Impact of a diagnosis of 'low-grade dysplasia' in patients with Barrett's esophagus.
    Dis Esophagus. 2026;39:doag028.
    PubMed     Abstract available
    
    
    
37. HAYES M, Gillman A, Elliott JA, Donohoe CL, et al
    The prevalence, nature and trajectory of oropharyngeal dysphagia within the first year following curative open resection for esophageal cancer.
    Dis Esophagus. 2026;39:doag029.
    PubMed     Abstract available
    
    
    
38. WANG W, Ye L, Ruan K, Li H, et al
    Retrospective analysis of the optimal timing of immunotherapy in patients with advanced esophageal squamous cell carcinoma: a window of opportunity.
    Dis Esophagus. 2026;39:doag038.
    PubMed     Abstract available
    
    
    
39. VAN DER AA DC, Khatib R, Eshuis WJ, Daams F, et al
    Postoperative pulmonary complications after esophagectomy: risk factors and prediction model.
    Dis Esophagus. 2026;39:doag041.
    PubMed     Abstract available
    
    
    
40. LEE WC, Yang CC, Chen YC, Ho CH, et al
    Incidence and risk factors of short-term cardiovascular events in esophageal cancer patients undergoing radiotherapy.
    Dis Esophagus. 2026;39:doag037.
    PubMed     Abstract available
    
    
    
41. MATSUI K, Miyawaki Y, Suzuki Y, Furube T, et al
    Relationship between immune-related adverse events and long-term survival in patients treated with immune checkpoint inhibitors for unresectable advanced or recurrent esophageal cancer.
    Dis Esophagus. 2026;39:doag036.
    PubMed     Abstract available
    
    
    
42. SUZUKI Y, Sarkaria IS, Kim S, Awais O, et al
    Regional characteristics of esophageal cancer and robot-assisted minimally invasive esophagectomy (RAMIE): an analysis of the international UGIRA registry.
    Dis Esophagus. 2026;39:doag042.
    PubMed     Abstract available
    
    
    
43. TATEISHI Y, Nakano K, Fujishima F, Nakanishi Y, et al
    Interobserver agreement in measuring submucosal invasion depth in pT1b-SM esophageal squamous cell carcinoma: practical implications for post-endoscopic resection treatment decision.
    Dis Esophagus. 2026;39:doag002.
    PubMed     Abstract available
    
    
    
44. HE H, Xu B, Liu H, Le C, et al
    Comparison of neoadjuvant chemoimmunotherapy with or without concurrent radiotherapy for locally advanced resectable esophageal squamous cell carcinoma: a multicenter retrospective study.
    Dis Esophagus. 2026;39:doag013.
    PubMed     Abstract available
    
    
    
45. LOURENSZ K, Wickremasinghe A, Bigwood S, Johari Y, et al
    Peristalsis of the gastric conduit post-esophagectomy: is it relevant? Detailed conduit analysis using dynamic magnetic resonance imaging.
    Dis Esophagus. 2026;39:doag045.
    PubMed     Abstract available
    
    
    
46. SANDERS ME, van der Horst S, Weijs TJ, Freund JE, et al
    Treatment strategies of esophageal cancer with concurrent cervical node metastasis: a Dutch nationwide population-based cohort study.
    Dis Esophagus. 2026;39:doag040.
    PubMed     Abstract available
    
    
    January 2026
47. TAKATSU J, Higaki E, Inada K, Yoshida M, et al
    Maximum pharyngeal constriction area: an independent predictor of sarcopenic dysphagia after esophageal cancer surgery.
    Dis Esophagus. 2026;39:doaf134.
    PubMed     Abstract available
    
    
    
48. BOSHIER PR, Gisbertz SS, Hanna GB, Klevebro F, et al
    Association of body composition, tumor-specific assessment, and patient demographics at diagnosis with 90-day and overall survival in esophageal cancer patients in a global population.
    Dis Esophagus. 2026;39:doaf128.
    PubMed     Abstract available
    
    
    
49. LI JK, Ou J, Su YX, Liao WH, et al
    Baseline dynamic contrast-enhanced magnetic resonance imaging derived parameters and magnetic resonance signal intensity based logistic regression model to predict response of esophageal squamous cell carcinoma to neoadjuvant immunochemotherapy.
    Dis Esophagus. 2026;39:doaf130.
    PubMed     Abstract available
    
    
    
50. FRANKEN IA, Busslinger G, Weusten BLAM, Brosens LAA, et al
    Patient-derived cancer organoids to tailor personalized treatment strategies in upper gastrointestinal malignancies.
    Dis Esophagus. 2026;39:doaf115.
    PubMed     Abstract available
    
    
    
51. VAN DOESBURG JR, Schuring N, Vries MHM, de Graaf P, et al
    Additional diagnostic value of cervical ultrasound in the detection of cervical lymph node metastases in patients with esophageal cancer.
    Dis Esophagus. 2026;39:doaf135.
    PubMed     Abstract available
    
    
    
52. CHEN C, Yuan C, Liu Z, Tan L, et al
    Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in China.
    Dis Esophagus. 2026;39:doaf137.
    PubMed     Abstract available
    
    
    
53. HUANG JQ, Xiao HM, Ma CX, Wang RZ, et al
    Chemoradiotherapy with versus without concurrent immune checkpoint inhibitor for locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study.
    Dis Esophagus. 2026;39:doag007.
    PubMed     Abstract available
    
    
    
54. BLONK L, Straatman J, Wierdsma NJ, Gisbertz SS, et al
    Nutritional aspects and quality of life in gastroesophageal cancer patients that underwent colonic interposition.
    Dis Esophagus. 2026;39:doaf126.
    PubMed     Abstract available
    
    
    
55. GORELIK Y, Mazzawi F, Beany A, Klein A, et al
    High accuracy of large language models in delivering recommendations for Barrett's esophagus management using real-world multilingual data-proof of concept study.
    Dis Esophagus. 2026;39:doaf136.
    PubMed     Abstract available
    
    
    
56. LIU C, Lee YY, Chien LI, Tao ZX, et al
    Nutritional and prognostic effects of thoracic duct obliteration during esophagectomy.
    Dis Esophagus. 2026;39:doag010.
    PubMed     Abstract available
    
    
    
57. ENKE T, Pokala SK, Hensen C, Brennan C, et al
    Recurrent Barrett's esophagus-related neoplasia is uncommon after successful endoscopic eradication therapy over long-term follow-up.
    Dis Esophagus. 2026;39:doag018.
    PubMed     Abstract available
    
    
    November 2025
58. KHALAF K, Hanna Y, Nishimura T, Li H, et al
    Risk stratification for stricture formation after endoscopic submucosal dissection for esophageal dysplasia.
    Dis Esophagus. 2025;38:doaf096.
    PubMed     Abstract available
    
    
    
59. JONES DG, Grimminger P, Reynolds J, Rosati R, et al
    Toward standardization in esophageal cancer surgery: patterns of practice across high-volume European centers.
    Dis Esophagus. 2025;38:doaf100.
    PubMed     Abstract available
    
    
    
60. TOSHIYAMA S, Honda M, Murakami M, Kikuchi Y, et al
    Proton beam-based chemoradiotherapy versus surgery plus adjuvant chemotherapy for esophageal squamous cell carcinoma: a comparison of the long-term survival from a single-center cohort study.
    Dis Esophagus. 2025;38:doaf099.
    PubMed     Abstract available
    
    
    
61. RUSIDANMU A, Yakufu Z, Zhou K, Zhu XX, et al
    Neoadjuvant chemoimmunotherapy cycles in locally advanced Esophageal squamous cell carcinoma: a retrospective comparison of three versus two cycles.
    Dis Esophagus. 2025;38:doaf101.
    PubMed     Abstract available
    
    
    
62. NA B, Kang CH, Park JH, Na KJ, et al
    Three-field lymph node dissection subsequent to neoadjuvant concurrent chemoradiotherapy in esophageal cancer.
    Dis Esophagus. 2025;38:doaf082.
    PubMed     Abstract available
    
    
    
63. SAWAS T, Benson JT, Allen A, Wang K, et al
    The metabolic profile of lean patients with esophageal adenocarcinoma and Barrett's esophagus.
    Dis Esophagus. 2025;38:doaf080.
    PubMed     Abstract available
    
    
    
64. ZENG W, Long J, Tan B, Li Y, et al
    Adjuvant immunotherapy in esophageal squamous cell carcinoma after radiotherapy: retrospective multicentric survival analysis.
    Dis Esophagus. 2025;38:doaf103.
    PubMed     Abstract available
    
    
    
65. TAKAHASHI N, Okamura A, Terayama M, Kato T, et al
    Risk factors of postoperative complications and prognostic factors in patients undergoing esophagectomy reconstructed with colonic interposition.
    Dis Esophagus. 2025;38:doaf117.
    PubMed     Abstract available
    
    
    
66. PERANANTHAN V, Iyer PG
    Recent advances in risk stratification of patients with Barrett's esophagus.
    Dis Esophagus. 2025;38:doaf110.
    PubMed     Abstract available
    
    
    
67. JIA S, Yin C, Li X, Yang L, et al
    A novel risk-scoring model for predicting cancer-specific mortality and instituting chemotherapy in elderly patients with esophageal cancer.
    Dis Esophagus. 2025;38:doaf108.
    PubMed     Abstract available
    
    
    
68. TANAKA I, Gantuya B, Ushikubo K, Yamamoto K, et al
    Post-endoscopy esophageal squamous cell carcinoma invading into muscularis mucosa or submucosal layer: a case series.
    Dis Esophagus. 2025;38:doaf122.
    PubMed     Abstract available
    
    
    
69. TAKAHASHI N, Okamura A, Terayama M, Kato T, et al
    Diagnostic performance of computed tomography short-axis diameter for supraclavicular lymph node metastasis after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Dis Esophagus. 2025;38:doaf121.
    PubMed     Abstract available
    
    
    
70. 
    Correction to: Peak expiratory flow predicts the occurrence of postoperative pneumonia after esophagectomy for esophageal cancer.
    Dis Esophagus. 2025;38:doaf124.
    PubMed    
    
    
    
71. ANDREWS WG, Blitz S, Sewell M, Molena D, et al
    The location and degree of residual disease determines recurrence patterns and survival in patients with esophageal adenocarcinoma after trimodal therapy.
    Dis Esophagus. 2025;38:doaf125.
    PubMed     Abstract available
    
    
    October 2025
72. MATSUDA S, Wijnhoven B, Lordick F, Bhandari P, et al
    Quality indicator survey of clinical practice guidelines for esophagogastric junction cancer 2023.
    Dis Esophagus. 2025;38:doaf071.
    PubMed     Abstract available
    
    
    September 2025
73. 
    Correction to: The prevalence, nature and severity of oropharyngeal dysphagia in the acute post-operative phase following curative resection for esophageal cancer.
    Dis Esophagus. 2025;38:doaf074.
    PubMed    
    
    
    
74. STRAATMAN J, Abu Hejley A, Klevebro F, Fuchs H, et al
    Analysis of in-hospital mortality following transthoracic esophagectomy for cancer.
    Dis Esophagus. 2025;38:doaf076.
    PubMed     Abstract available
    
    
    
75. KOOIJ CD, Goense L, Kingma BF, den Boer RB, et al
    Early versus late oral feeding regimens following esophagectomy: a propensity score-matched observational cohort.
    Dis Esophagus. 2025;38:doaf068.
    PubMed     Abstract available
    
    
    
76. DE MUL N, Vernooij LM, van Haastregt NCJ, de Groot EM, et al
    Judicious use of critical care resources by predicting the need for routine ICU admission following esophagectomy.
    Dis Esophagus. 2025;38:doaf075.
    PubMed     Abstract available
    
    
    
77. SEURS W, Van Veer H, Nafteux P, Depypere L, et al
    Are insufficient diagnostic criteria for anastomotic leakage after esophagectomy harming our patients?
    Dis Esophagus. 2025;38:doaf081.
    PubMed     Abstract available
    
    
    
78. KOROMA P, Chaudhury M, Shetty V, Turner P, et al
    Chyle leak following esophagectomy: 'a retrospective 10-year single-site experience of a tertiary center'.
    Dis Esophagus. 2025;38:doaf083.
    PubMed     Abstract available
    
    
    
79. COLE K, Gossage JA, Bhandari P, Blencowe NS, et al
    Impact of staging investigations on nodal upstaging in early esophago-gastric adenocarcinoma: multicenter CONGRESS dataset analysis.
    Dis Esophagus. 2025;38:doaf085.
    PubMed     Abstract available
    
    
    
80. FARNQVIST K, Malberg K, Johnsson SI, Johar A, et al
    Health-related quality of life in esophageal cancer: a state-of-the-art review of patient-reported outcomes and an evidence and gap map.
    Dis Esophagus. 2025;38:doaf086.
    PubMed     Abstract available
    
    
    
81. SCHNEIDER MA, Viggiani D'Avalos L, Gerdes S, Vetter D, et al
    Delayed gastric conduit emptying after esophagectomy: attempt at a clinically relevant classification.
    Dis Esophagus. 2025;38:doaf090.
    PubMed     Abstract available
    
    
    
82. OHSAWA M, Hamai Y, Emi M, Ibuki Y, et al
    Treatment outcomes of esophageal squamous cell carcinoma with cM1 lymph node without organ metastasis.
    Dis Esophagus. 2025;38:doaf095.
    PubMed     Abstract available
    
    
    
83. KOHDA M, Imano M, Kato H, Shinkai M, et al
    Validity of using plastic bags to wrap the esophagus after the thoracic procedure during radical esophageal cancer surgery.
    Dis Esophagus. 2025;38:doaf093.
    PubMed     Abstract available
    
    
    
84. 
    Correction to: Health-related quality of life in esophageal cancer: a state-of-the-art review of patient-reported outcomes and an evidence and gap map.
    Dis Esophagus. 2025;38:doaf097.
    PubMed    
    
    
    July 2025
85. HAYES M, Gillman A, Elliott JA, Donohoe CL, et al
    The prevalence, nature and severity of oropharyngeal dysphagia in the acute post-operative phase following curative resection for esophageal cancer.
    Dis Esophagus. 2025;38:doaf054.
    PubMed     Abstract available
    
    
    
86. WATANABE Y, Iida M, Nishiyama M, Nakashima C, et al
    Preoperative sarcopenia predicts complications and non-cancer specific mortality in esophageal cancer surgery.
    Dis Esophagus. 2025;38:doaf056.
    PubMed     Abstract available
    
    
    
87. TRUIJEN SPM, Vissers PAJ, Nieuwenhuijzen GAP, van der Sangen MJC, et al
    A cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients.
    Dis Esophagus. 2025;38:doaf057.
    PubMed     Abstract available
    
    
    
88. FENG Z, Li M, Cui B, Wang L, et al
    Patterns of toxic side effects and prognostic factors in concurrent chemoradiotherapy for esophageal cancer.
    Dis Esophagus. 2025;38:doaf060.
    PubMed     Abstract available
    
    
    
89. CHEVALLAY M, Barman S, Moss C, Van Hemelrijck M, et al
    Development of a symptom response to treatment questionnaire for patients in follow-up after oesophago-gastrectomy for cancer.
    Dis Esophagus. 2025;38:doaf063.
    PubMed     Abstract available
    
    
    
90. DEN BOER RB, Sanders ME, Meijer GJ, Haj Mohammad N, et al
    Impact of endoscopic ultrasonography with fine needle aspiration assessing clinical lymph node staging on radiotherapy treatment planning in esophageal cancer patients.
    Dis Esophagus. 2025;38:doaf065.
    PubMed     Abstract available
    
    
    
91. KO MT, Rizwanullah A, Jafri Z, Fung A, et al
    Chemoprevention of Barrett's Esophagus: a Systematic Review and Comprehensive Assessment of Bias.
    Dis Esophagus. 2025;38:doaf062.
    PubMed     Abstract available
    
    
    
92. KEMPF ON, Thorsen LBJ, Nerup N, Kjaer DW, et al
    Stage-dependent survival in esophageal cancer: a Danish nationwide cohort study.
    Dis Esophagus. 2025;38:doaf064.
    PubMed     Abstract available
    
    
    
93. CHEVALLAY M, Barman S, Moss C, Van Hemelrijck M, et al
    Impact of endoscopic pyloric dilatation on symptom relief in delayed gastric emptying after esophageal resection-use of a novel symptom response questionnaire.
    Dis Esophagus. 2025;38:doaf067.
    PubMed     Abstract available
    
    
    
94. TANKEL J, Amin S, Katz A, Sakalla R, et al
    Gastric conduit necrosis following esophagectomy: is conduit salvage feasible?
    Dis Esophagus. 2025;38:doaf066.
    PubMed     Abstract available
    
    
    May 2025
95. ZHU G, Song X, Wang Q, Zhang Z, et al
    Effects of immunoenteric nutrition versus general enteral nutrition on prognosis in patients with squamous cell carcinoma undergoing radical esophagectomy post neoadjuvant chemotherapy.
    Dis Esophagus. 2025;38:doaf027.
    PubMed     Abstract available
    
    
    
96. WANG M, Wang X, Liu Z, Shen H, et al
    Recurrence patterns following neoadjuvant chemotherapy combined with immunotherapy for esophageal squamous cell carcinoma.
    Dis Esophagus. 2025;38:doaf034.
    PubMed     Abstract available
    
    
    
97. RICCIO F, Klarenbeek BR, Fujiwara H, Seto Y, et al
    Worldwide survey on the transcervical approach for minimally invasive treatment of esophageal cancer: results of questionnaire of the international collaborative group on transCervical Minimally Invasive Esophagectomy.
    Dis Esophagus. 2025;38:doaf035.
    PubMed     Abstract available
    
    
    
98. CHIEN S, Glen P
    Impact on Barrett's dysplasia yield following the introduction of capsule sponge testing versus traditional endoscopic surveillance.
    Dis Esophagus. 2025;38:doaf033.
    PubMed     Abstract available
    
    
    
99. VISSAPRAGADA R, Bulamu NB, Whiteman DC, Bright T, et al
    Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett's esophagus.
    Dis Esophagus. 2025;38:doaf038.
    PubMed     Abstract available
    
    
    
100. DAMTOFT A, Osterkamp J, Olsen AA, De Heer P, et al
     Incidence of delayed gastric conduit emptying after esophagectomy: a retrospective single-center study.
     Dis Esophagus. 2025;38:doaf040.
     PubMed     Abstract available
     
     
     
101. KOOIJ CD, de Groot EM, Goense L, Kingma BF, et al
     The effect of prophylactic cruroplasty on the incidence of hiatal herniation after robot-assisted minimally invasive esophagectomy (RAMIE).
     Dis Esophagus. 2025;38:doaf041.
     PubMed     Abstract available
     
     
     
102. MARTINS BC, Gregorio JM, Sueta RU, Centeno DM, et al
     Efficacy and safety of self-expanding metal stents in advanced esophageal cancer: a 12-year analysis in a referral center.
     Dis Esophagus. 2025;38:doaf039.
     PubMed     Abstract available
     
     
     
103. LV Z, Yuan L, Mao Y, Ai S, et al
     Recurrent laryngeal nerve paralysis as a potential mediator of complications in esophagectomy following lymph node dissection.
     Dis Esophagus. 2025;38:doaf028.
     PubMed     Abstract available
     
     
     
104. HARRIS TR, Elkamel AAA, Wang K, Abdalgadir M, et al
     Predictors of overall survival in esophageal cancer patients with pathologic complete response after neoadjuvant therapy and surgery.
     Dis Esophagus. 2025;38:doaf043.
     PubMed     Abstract available
     
     
     
105. CRUMP T, Dehghani M, Sutherland JM, Mueller C, et al
     Calculating the minimally important difference for the FACT-E from esophageal cancer surgery to recovery using distribution-based methods.
     Dis Esophagus. 2025;38:doaf042.
     PubMed     Abstract available
     
     
     
106. SUGASE T, Kanemura T, Matsuura N, Sugimura K, et al
     Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma.
     Dis Esophagus. 2025;38:doaf029.
     PubMed     Abstract available
     
     
     
107. LYE TJ, Chiu CH, Chao YK
     Association between recurrent laryngeal nerve diameter and postoperative palsy following robot-assisted minimally invasive esophagectomy.
     Dis Esophagus. 2025;38:doaf048.
     PubMed     Abstract available
     
     
     
108. MARKAR SR, Van Berge Henegouwen M, Bruns C, Ferri L, et al
     Does the SANO trial really move us toward organ preservation for esophageal cancer?
     Dis Esophagus. 2025;38:doaf049.
     PubMed    
     
     
     
109. YANG P, Xue B, Liu T, Qi L, et al
     Prognostic impact of recurrent laryngeal nerve lymph node metastatic status in thoracic esophageal squamous cell carcinoma.
     Dis Esophagus. 2025;38:doaf052.
     PubMed     Abstract available
     
     
     March 2025
110. MUCHA AW, Strandby RB, Nerup NA, Achiam MP, et al
     Treatment of intrathoracic anastomotic leakage following esophagectomy for gastroesophageal cancer: a systematic review.
     Dis Esophagus. 2025;38:doaf016.
     PubMed     Abstract available
     
     
     
111. LIU D, Liang HW, Liu Y, Huang W, et al
     Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study.
     Dis Esophagus. 2025;38:doaf017.
     PubMed     Abstract available
     
     
     
112. NG AYL, Goense L, Van De Horst S, Van Den Berg JW, et al
     Robotic- assisted minimally invasive Ivor-Lewis handsewn anastomosis technique and outcomes from a large-volume European centre.
     Dis Esophagus. 2025;38:doaf019.
     PubMed     Abstract available
     
     
     
113. SAEED U, Myklebust TA, Robsahm TE, Aune D, et al
     Associations between body mass index and gastroesophageal cancer incidence and mortality: novel insights from a nationwide registry-based cohort study.
     Dis Esophagus. 2025;38:doaf018.
     PubMed     Abstract available
     
     
     January 2025
114. KENNELLY P, Davey MG, Griniouk D, Calpin G, et al
     Evaluating the impact of enhanced recovery after surgery protocols following oesophagectomy: a systematic review and meta-analysis of randomised clinical trials.
     Dis Esophagus. 2025;38:doae118.
     PubMed     Abstract available
     
     
     
115. TAKEBAYASHI K, Kaida S, Otake R, Fukuo A, et al
     HMB/Arg/Gln may improve short-term outcomes after esophagectomy in patients with thoracic esophageal cancer.
     Dis Esophagus. 2025;38:doae121.
     PubMed     Abstract available
     
     
     
116. ZHOU MJ, Hsing AW, Clarke JO
     Prevalence and predictors of Barrett's esophagus and esophageal cancer in patients with eosinophilic esophagitis.
     Dis Esophagus. 2025;38:doae120.
     PubMed     Abstract available
     
     
     
117. TRAVIS D, Nnawuba K, Vellanki S, Robinson S, et al
     Demographic analysis of survival trends in squamous cell carcinoma of the upper 1/3 of the esophagus: a population-based study.
     Dis Esophagus. 2025;38:doae111.
     PubMed     Abstract available
     
     
     
118. OSTERKAMP JTF, Nerup N, Svendsen MBS, Strandby RB, et al
     Central ligation or partial preservation of the right gastric artery does not seem to affect conduit or anastomotic perfusion during robot-assisted resection of gastroesophageal junction cancer: a randomized clinical trial.
     Dis Esophagus. 2025;38:doae102.
     PubMed     Abstract available
     
     
     
119. GEERTS JFM, van den Berg I, van Nistelrooij AMJ, Lagarde SM, et al
     Risk factors for readmission following esophagectomy and gastrectomy for cancer.
     Dis Esophagus. 2025;38:doae101.
     PubMed     Abstract available
     
     
     
120. OKUMURA T, Miwa T, Murotani K, Numata Y, et al
     Modified reconstruction procedure in subtotal esophagectomy with retrosternal gastric pull up to reduce anastomotic leakage: a propensity score-matched analysis.
     Dis Esophagus. 2025;38:doae100.
     PubMed     Abstract available
     
     
     
121. CAUSH L, Church J, Goodall S, Lord RV, et al
     Factors influencing the cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia in Australia.
     Dis Esophagus. 2025;38:doae095.
     PubMed     Abstract available
     
     
     
122. IGAUE S, Nozaki R, Utsunomiya D, Kubo Y, et al
     Treatment strategy involving docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery for locally advanced unresectable/borderline resectable esophageal squamous cell carcinoma.
     Dis Esophagus. 2025;38:doae114.
     PubMed     Abstract available
     
     
     
123. MARKAR S, Mariette C, Bonnetain F, Lundell L, et al
     Immunonutrition to improve the quality of life of upper gastrointestinal cancer patients undergoing neoadjuvant treatment prior to surgery (NEOIMMUNE): double-blind randomized controlled multicenter clinical trial.
     Dis Esophagus. 2025;38:doae113.
     PubMed     Abstract available
     
     
     
124. WALMSLEY JA, Abdelrahman M, Ariyarathenam A, Berrisford R, et al
     Prognostic significance of subcarinal lymph node involvement in patients with Siewert type I and II gastro-esophageal junctional adenocarcinoma: an analysis of 698 patients undergoing Ivor-Lewis esophagectomy.
     Dis Esophagus. 2025;38:doaf003.
     PubMed     Abstract available
     
     
     
125. YANG T, Yang P, Li H, Sun M, et al
     Association of treatment methods and survival in esophageal neuroendocrine carcinoma population of Surveillance, Epidemiology, and End Results database: a retrospective cohort study.
     Dis Esophagus. 2025;38:doaf008.
     PubMed     Abstract available
     
     
     
126. ZHENG B, Huang G, Zeng T, Zhang S, et al
     Optimal extent of left recurrent laryngeal nerve para-lymph node dissection in esophageal squamous cell carcinoma: a retrospective analysis based on cytokeratin 19 immunopositivity for micrometastasis detection.
     Dis Esophagus. 2025;38:doae106.
     PubMed     Abstract available
     
     
     
127. ROMPEN IF, Yilmazcelik B, Crnovrsanin N, Schiefer S, et al
     Minimally invasive resection is associated with decreased occurrence of early delayed gastric conduit emptying after Ivor-Lewis esophagectomy.
     Dis Esophagus. 2025;38:doaf006.
     PubMed     Abstract available
     
     
     
128. YE W, Leng C, Chen J, Mai Z, et al
     Characteristics analyses and tumor staging proposal for primary malignant melanoma of the esophagus: a retrospective study.
     Dis Esophagus. 2025;38:doaf009.
     PubMed     Abstract available
     
     
     
129. YAGI K, Aikou S, Yajima S, Urabe M, et al
     Survival outcomes of robot-assisted transmediastinal esophagectomy in patients with esophageal squamous cell carcinoma.
     Dis Esophagus. 2025;38:doaf007.
     PubMed     Abstract available
     
     
     
130. KURIYAMA K, Okamura A, Hayami M, Kanamori J, et al
     Is prophylactic lymph node dissection efficacious in salvage esophagectomy after definitive chemoradiotherapy?
     Dis Esophagus. 2025;38:doaf004.
     PubMed     Abstract available
     
     
     
131. ZHOU G, Ding X, Wang M, Tong Y, et al
     Feasibility and safety of interventional radiology-guided biopsy for esophageal stenosis.
     Dis Esophagus. 2025;38:doaf005.
     PubMed     Abstract available
     
     
     
132. LUO B, Yang Y, Huang Y
     A preliminary investigation of blood cell counts for esophageal cancer screening: differentiating esophageal cancer from gastroesophageal reflux disease.
     Dis Esophagus. 2025;38:doaf025.
     PubMed     Abstract available
     
     
     December 2024
133. TERAYAMA M, Okamura A, Oki A, Kuriyama K, et al
     Predictive factors for failure of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy in esophageal squamous cell carcinoma.
     Dis Esophagus. 2024 Dec 19:doae115. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. PEYSER CARDOSO R, Agarwal L, Cardoso SA, Agarwal A, et al
     Impact of intraoperative recurrent laryngeal nerve monitoring on minimally invasive esophagectomy outcomes for esophageal cancer: a meta-analysis of case-control studies.
     Dis Esophagus. 2024 Dec 19:doae116. doi: 10.1093.
     PubMed     Abstract available
     
     
     
135. KWON Y, Yun JK, Lee GD, Choi SH, et al
     Gastric conduit in patients with previous endoscopic resection of the stomach for esophageal squamous cell carcinoma.
     Dis Esophagus. 2024 Dec 7:doae112. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2024
136. CHEN J, Wang Z, Huang J, Zhang Y, et al
     Experimental study on radiational characteristics and nursing care of a novel radioisotope 188Re memory alloy esophageal stent.
     Dis Esophagus. 2024;37:doae088.
     PubMed     Abstract available
     
     
     
137. MINAKATA N, Kadota T, Sakashita S, Inaba A, et al
     Tumor thickness is associated with metastasis in patients with submucosal invasive adenocarcinoma of the esophagogastric junction.
     Dis Esophagus. 2024;37:doae083.
     PubMed     Abstract available
     
     
     
138. MOONS J, Declerck H, Gijbels E, Jans M, et al
     Evaluation of patient satisfaction with an enhanced recovery protocol for esophageal resections: a concurrent quantitative and qualitative analysis.
     Dis Esophagus. 2024;37:doae079.
     PubMed     Abstract available
     
     
     
139. DONATO BB, Campany ME, Brady JT, Jenkins JA, et al
     Complete pathologic response in esophageal adenocarcinoma: does it make a difference?
     Dis Esophagus. 2024;37:doae068.
     PubMed     Abstract available
     
     
     
140. ROSMOLEN WD, Pouw RE, Bergman JJ, Sprangers MAG, et al
     Reasons for fear of cancer recurrence after endoscopic treatment of T1 esophageal adenocarcinoma. A semi-structured interview study.
     Dis Esophagus. 2024;37:doae067.
     PubMed     Abstract available
     
     
     
141. LIU C, Lan TL, Tsai PC, Chien LI, et al
     Managing esophageal squamous cell carcinoma after cervical radiotherapy for a head and neck cancer: esophagectomy remains a viable option.
     Dis Esophagus. 2024 Nov 7:doae099. doi: 10.1093.
     PubMed     Abstract available
     
     
     
142. HARADA T, Tsuji T, Ueno J, Konishi N, et al
     Clinical mechanism of muscle mass loss during neoadjuvant chemotherapy in older patients with esophageal cancer: a prospective cohort study.
     Dis Esophagus. 2024 Nov 5:doae096. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2024
143. BEVERS KC, Sewell M, Bott MJ, Sihag S, et al
     Gastric preconditioning via percutaneous angioembolization before esophagectomy in patients at high risk for esophageal leak.
     Dis Esophagus. 2024;37:doae062.
     PubMed     Abstract available
     
     
     
144. BLONK L, Gooszen JAH, Fakkert RA, Eshuis WJ, et al
     Micronutrient deficiencies and anemia in the follow-up after gastroesophageal cancer surgery.
     Dis Esophagus. 2024;37:doae053.
     PubMed     Abstract available
     
     
     
145. AHMED R, Elliott JA, Blaser M, Donohoe CL, et al
     Paraconduit hiatus hernia after esophageal cancer surgery: incidence, risk factors, and management.
     Dis Esophagus. 2024 Oct 28:doae093. doi: 10.1093.
     PubMed     Abstract available
     
     
     
146. SAWAI S, Nakatani E, Sato S, Hawke P, et al
     Peak expiratory flow predicts the occurrence of postoperative pneumonia after esophagectomy for esophageal cancer.
     Dis Esophagus. 2024 Oct 10:doae084. doi: 10.1093.
     PubMed     Abstract available
     
     
     
147. PATTON A, Davey MG, Quinn E, Reinhardt C, et al
     Minimally invasive vs open vs hybrid esophagectomy for esophageal cancer: a systematic review and network meta-analysis.
     Dis Esophagus. 2024 Oct 10:doae086. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. ST-PIERRE J, Coca-Martinez M, Drummond K, Minnella E, et al
     Multimodal prehabilitation to enhance functional capacity of patients with esophageal cancer during concurrent neoadjuvant chemotherapies-a randomized feasibility trial.
     Dis Esophagus. 2024 Oct 8:doae087. doi: 10.1093.
     PubMed     Abstract available
     
     
     
149. TANKEL J, Nevo Y, Al Shehhi R, Sakalla R, et al
     Impact of bulky loco-regional lymphadenopathy in esophageal adenocarcinoma on survival: a retrospective single center analysis.
     Dis Esophagus. 2024;37:doae046.
     PubMed     Abstract available
     
     
     
150. LOUGHNEY L, Murphy K, Tully R, Robb WB, et al
     The effect of a pre- and post-operative exercise program versus standard care on physical activity and sedentary behavior of patients with esophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (the PERIOP-OG Trial): a randomi
     Dis Esophagus. 2024;37:doae044.
     PubMed     Abstract available
     
     
     
151. WATANABE M, Takahashi N, Tamura M, Terayama M, et al
     Gastric conduit reconstruction after esophagectomy.
     Dis Esophagus. 2024;37:doae045.
     PubMed     Abstract available
     
     
     September 2024
152. HAMRAH MH, Kanda M, Sato Y, Zhu H, et al
     Expression profile and function of secretogranin V, and its effects on the malignant behavior of esophageal squamous cell carcinoma.
     Dis Esophagus. 2024 Sep 26:doae075. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2024
153. HAUGE T, Dretvik T, Johnson E, Mala T, et al
     Treatment of anastomotic leakage following Ivor Lewis esophagectomy-10 year experience from a Nordic center.
     Dis Esophagus. 2024;37:doae040.
     PubMed     Abstract available
     
     
     
154. KLEVEBRO F, Ash S, Mueller C, Garbarino GM, et al
     Contemporary outcomes of left thoraco-abdominal esophagectomy due to cancer in the esophagus or gastroesophageal junction, a multicenter cohort study.
     Dis Esophagus. 2024;37:doae039.
     PubMed     Abstract available
     
     
     
155. SUZUKI Y, Kikuchi D, Nakamura S, Iizuka T, et al
     Endoscopic submucosal dissection for superficial esophageal cancer in the remnant esophagus after esophagectomy.
     Dis Esophagus. 2024 Aug 26:doae070. doi: 10.1093.
     PubMed     Abstract available
     
     
     
156. LIU C, Tsai PC, Chien LI, Huang CS, et al
     Esophagectomy in patients with esophageal squamous cell carcinoma and distant nodal metastasis.
     Dis Esophagus. 2024 Aug 16:doae064. doi: 10.1093.
     PubMed     Abstract available
     
     
     
157. LV Z, Yuan L, He J, Gao S, et al
     Time-dependent prognostic impact of circumferential resection margin in T3 thoracic esophageal squamous cell carcinoma.
     Dis Esophagus. 2024 Aug 14:doae065. doi: 10.1093.
     PubMed     Abstract available
     
     
     
158. LIATSOU E, Bellos I, Katsaros I, Michailidou S, et al
     Sex differences in survival following surgery for esophageal cancer: A systematic review and meta-analysis.
     Dis Esophagus. 2024 Aug 14:doae063. doi: 10.1093.
     PubMed     Abstract available
     
     
     
159. LINDBLAD M, Jestin C, Johansson J, Edholm D, et al
     Multidisciplinary team meetings improve survival in patients with esophageal cancer.
     Dis Esophagus. 2024 Aug 9:doae061. doi: 10.1093.
     PubMed     Abstract available
     
     
     
160. VAN GEFFEN EGM, Neelis KJ, Putter H, Slingerland M, et al
     Esophagectomy after definitive chemoradiation in esophageal cancer: a safe therapeutic strategy.
     Dis Esophagus. 2024 Aug 8:doae059. doi: 10.1093.
     PubMed     Abstract available
     
     
     
161. SHIGENO T, Otomo M, Kajiyama D, Sato K, et al
     Assessing the outcomes of posterior thoracic para-aortic lymph node dissection after induction chemotherapy in patients with esophageal squamous cell carcinoma.
     Dis Esophagus. 2024 Aug 2:doae060. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2024
162. NORTON BC, Aslam N, Telese A, Papaefthymiou A, et al
     Risk of metastasis among patients diagnosed with high-risk T1 esophageal adenocarcinoma who underwent endoscopic follow-up.
     Dis Esophagus. 2024;37:doae027.
     PubMed     Abstract available
     
     
     
163. PAPACONSTANTINOU D, Koliakos N, Tzortzis AS, Mandrakas N, et al
     Role of thoracic endovascular aortic repair in T4b esophageal cancer management: a systematic review.
     Dis Esophagus. 2024 Jul 26:doae058. doi: 10.1093.
     PubMed     Abstract available
     
     
     
164. 
     Correction to: Performance of a consensus-based algorithm for diagnosing anastomotic leak after minimally invasive esophagectomy for esophageal cancer.
     Dis Esophagus. 2024 Jul 5:doae056. doi: 10.1093.
     PubMed    
     
     
     
165. KANG CH, Yun TY, Park JH, Na B, et al
     Long-term survival analysis of robotic esophagectomy for esophageal cancer.
     Dis Esophagus. 2024 Jul 4:doae054. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. VELAYUDHAM GK, Dermanis A, Kamarajah SK, Griffiths EA, et al
     Predictors of textbook outcome following oesophagogastric cancer surgery.
     Dis Esophagus. 2024;37:doae023.
     PubMed     Abstract available
     
     
     
167. WIJNHOVEN BPL, Griffiths EA
     Diagnosis and treatment of junctional cancer from a global perspective.
     Dis Esophagus. 2024;37:doae017.
     PubMed    
     
     
     June 2024
168. WANG CZ, Zhang HL, Shang QX, Gu YM, et al
     Mapping of lymph node metastasis from esophageal squamous cell carcinoma after neoadjuvant treatment: a prospective analysis from a high-volume institution in China.
     Dis Esophagus. 2024 Jun 17:doae052. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. TANAKA I, Hatta W, Koike T, Takahashi S, et al
     Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer.
     Dis Esophagus. 2024 Jun 13:doae048. doi: 10.1093.
     PubMed     Abstract available
     
     
     
170. VAN DER ZIJDEN CJ, Bouwman A, Mostert B, Nuyttens JJME, et al
     Overall survival after definitive chemoradiotherapy for patients with esophageal cancer: a retrospective cohort study.
     Dis Esophagus. 2024 Jun 5:doae047. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. REDDY AT, Lee JP, Leiman DA
     Measuring and improving quality in esophageal care and swallowing disorders.
     Dis Esophagus. 2024;37:doae013.
     PubMed     Abstract available
     
     
     
172. NGUYEN CL, Tovmassian D, Isaacs A, Falk GL, et al
     Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a meta-analysis.
     Dis Esophagus. 2024;37:doae012.
     PubMed     Abstract available
     
     
     
173. HEDBERG J, Sundbom M, Edholm D, Aahlin EK, et al
     Randomized controlled trial of nasogastric tube use after esophagectomy: study protocol for the kinetic trial.
     Dis Esophagus. 2024;37:doae010.
     PubMed     Abstract available
     
     
     May 2024
174. SHIRAISHI O, Hagi T, Hiraki Y, Kato H, et al
     Risk factors and prognosis for supraclavicular lymph node metastasis in patients with thoracic esophageal cancer. Distant or regional metastasis?
     Dis Esophagus. 2024 May 14:doae042. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. MIYATA H, Sugimura K, Kanemura T, Takeoka T, et al
     Prognostic impact of nodal status and lymphovascular invasion in patients undergoing neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
     Dis Esophagus. 2024 May 1:doae038. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2024
176. CHIEN S, Glen P, Penman I, Bryce G, et al
     National adoption of an esophageal cell collection device for Barrett's esophagus surveillance: impact on delay to investigation and pathological findings.
     Dis Esophagus. 2024;37:doae002.
     PubMed     Abstract available
     
     
     
177. VISSER MR, van Berge Henegouwen MI, van Hillegersberg R
     Centralization and Quality Control in Esophageal Cancer Surgery: a Way Forward in Europe.
     Dis Esophagus. 2024 Apr 26:doae035. doi: 10.1093.
     PubMed    
     
     
     
178. VISSER MR, Voeten DM, Gisbertz SS, Ruurda JP, et al
     Western European Variation in the Organization of Esophageal Cancer Surgical Care.
     Dis Esophagus. 2024 Apr 26:doae033. doi: 10.1093.
     PubMed     Abstract available
     
     
     
179. MATSUMOTO S, Wakatsuki K, Nakade H, Kunishige T, et al
     Association of perioperative oral swallowing function with post-esophagectomy outcomes and nutritional statuses in patients with esophageal cancer.
     Dis Esophagus. 2024 Apr 25:doae032. doi: 10.1093.
     PubMed     Abstract available
     
     
     
180. JEON YJ, Han K, Lee SW, Lee JE, et al
     Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study.
     Dis Esophagus. 2024 Apr 8:doae029. doi: 10.1093.
     PubMed     Abstract available
     
     
     
181. ZHANG GL, Zhu QK, Ma TY, Weng CG, et al
     Clinical study of camrelizumab combined with docetaxel and carboplatin as a neoadjuvant treatment for locally advanced oesophageal squamous cell carcinoma.
     Dis Esophagus. 2024;37:doad073.
     PubMed     Abstract available
     
     
     
182. YUNRONG T, Jin WW, Mahendran HA, Koon YB, et al
     Pre-operative psoas muscle index, a surrogate for sarcopenia; as a predictor of post-esophagectomy complications.
     Dis Esophagus. 2024;37:doad072.
     PubMed     Abstract available
     
     
     March 2024
183. PEI S, Huang JQ, Liang HW, Liu Y, et al
     Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery.
     Dis Esophagus. 2024 Mar 28:doae026. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. FURUE Y, Yoda Y, Hori K, Nakajo K, et al
     Outcomes of repeated endoscopic submucosal dissection for superficial Esophageal squamous cell carcinoma on endoscopic resection scar.
     Dis Esophagus. 2024 Mar 28:doae018. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. PATEL J, Khanna T, Sohal A, Dhaliwal A, et al
     Impact of aspirin use on rates of metastasis in patients with esophageal cancer: insights from the National Inpatient Sample.
     Dis Esophagus. 2024 Mar 24:doae022. doi: 10.1093.
     PubMed     Abstract available
     
     
     
186. BABIC B, Mueller DT, Krones TL, Schiffmann LM, et al
     A senior surgical resident can safely perform complex esophageal cancer surgery after surgical mentoring program-experience of a European high-volume center.
     Dis Esophagus. 2024 Mar 8:doae015. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2024
187. AN KR, Seijas V, Xu MS, Grusser L, et al
     Does prehabilitation before esophagectomy improve postoperative outcomes? A systematic review and meta-analysis.
     Dis Esophagus. 2024;37:doad066.
     PubMed     Abstract available
     
     
     
188. PELZNER K, Fuchs C, Petersen M, Maus M, et al
     Sex- and gender-specific differences in symptoms and health-related quality of life among patients with gastroesophageal reflux disease.
     Dis Esophagus. 2024;37:doad064.
     PubMed     Abstract available
     
     
     January 2024
189. MENGARDO V, Weindelmayer J, Ceccherini G, Wilkinson M, et al
     The effect of aging on short- and long-term results after esophagectomy: an international multicenter retrospective analysis.
     Dis Esophagus. 2024;37:doad057.
     PubMed     Abstract available
     
     
     
190. THAMMINEEDI SR, Patnaik SC, Nusrath S, Naik V, et al
     Evaluation of indocyanine green tracheobronchial fluorescence (ICG-TBF) via nebulization during minimally invasive esophagectomy.
     Dis Esophagus. 2024;37:doad059.
     PubMed     Abstract available
     
     
     
191. GILLMAN A, Kenny C, Hayes M, Walshe M, et al
     Nature, severity, and impact of chronic oropharyngeal dysphagia following curative resection for esophageal cancer: a cross-sectional study.
     Dis Esophagus. 2024 Jan 23:doae003. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. CHO H, Abe S, Nonaka S, Suzuki H, et al
     Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
     Dis Esophagus. 2024 Jan 23:doae004. doi: 10.1093.
     PubMed     Abstract available
     
     
     
193. DE GROOT EM, Kingma BF, Goense L, van der Kaaij NP, et al
     Surgical treatment of esophago-tracheobronchial fistulas after esophagectomy.
     Dis Esophagus. 2024;37:doad054.
     PubMed     Abstract available
     
     
     
194. YAN S, Liu X, Xing W, Jiang D, et al
     The prognostic impact of tumor length on pathological stage IA-IC esophageal adenocarcinoma.
     Dis Esophagus. 2024;37:doad046.
     PubMed     Abstract available
     
     
     December 2023
195. SCHURING N, van Berge Henegouwen MI, Gisbertz SS
     History and evidence for state of the art of lymphadenectomy in esophageal cancer surgery.
     Dis Esophagus. 2023 Dec 4:doad065. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2023
196. AHMED N, Tankel J, Asselah J, Alcindor T, et al
     Survival and perioperative outcomes of octo- and nonagenarians with resectable esophageal carcinoma.
     Dis Esophagus. 2023;36:doad043.
     PubMed     Abstract available
     
     
     
197. WALMSLEY J, Ariyarathenam A, Berrisford R, Humphreys L, et al
     Systematic review of quality of life after esophagectomy and total gastrectomy in patients with gastro-esophageal junction cancer.
     Dis Esophagus. 2023;36:doad039.
     PubMed     Abstract available
     
     
     
198. 
     Correction to: 176. NON-REGIONAL LYMPHADENOPATHY IN PATIENTS WITH ESOPHAGEAL CANCER TREATED WITH CURATIVE INTENT: A PROPENSITY MATCHED ANALYSIS OF PATHOLOGICAL AND SURVIVAL OUTCOMES.
     Dis Esophagus. 2023 Nov 21:doad067. doi: 10.1093.
     PubMed    
     
     
     October 2023
199. ELLIOTT JA, Guinan E, Reynolds JV
     Measurement and optimization of perioperative risk among patients undergoing surgery for esophageal cancer.
     Dis Esophagus. 2023 Oct 28:doad062. doi: 10.1093.
     PubMed     Abstract available
     
     
     
200. TIAN Y, Xue C, Li X, Bai J, et al
     Efficacy and safety of modified endoscopic submucosal tunnel dissection for superficial esophageal circumferential lesions.
     Dis Esophagus. 2023;36:doad035.
     PubMed     Abstract available
     
     
     
201. TAKEUCHI A, Ojima T, Hayata K, Kitadani J, et al
     Laparoscopic reconstruction in McKeown esophagectomy is a risk factor for postoperative diaphragmatic hernia.
     Dis Esophagus. 2023;36:doad037.
     PubMed     Abstract available
     
     
     
202. ALVARADO CE, Worrell SG, Sarode AL, Bassiri A, et al
     Disparities and access to thoracic surgeons among esophagectomy patients in the United States.
     Dis Esophagus. 2023;36:doad025.
     PubMed     Abstract available
     
     
     
203. DE GROOT E, Schiffmann LM, van der Veen A, Borggreve A, et al
     Laparoscopic ischemic conditioning prior esophagectomy in selected patients: the ISCON trial.
     Dis Esophagus. 2023;36:doad027.
     PubMed     Abstract available
     
     
     September 2023
204. REYHANI A, Gimson E, Baker C, Kelly M, et al
     Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma.
     Dis Esophagus. 2023;36:doad020.
     PubMed     Abstract available
     
     
     
205. CROWE BR, Krigel A, Li T, Haile R, et al
     Veterans with multiple risk factors for Barrett's esophagus are infrequently evaluated with upper endoscopy.
     Dis Esophagus. 2023;36:doad007.
     PubMed     Abstract available
     
     
     
206. CHAN KS, Oo AM
     Exploring the learning curve in minimally invasive esophagectomy: a systematic review.
     Dis Esophagus. 2023;36:doad008.
     PubMed     Abstract available
     
     
     
207. YASUDA T, Matsuda A, Arai H, Kakinuma D, et al
     Feeding gastrostomy and duodenostomy using the round ligament of the liver versus conventional feeding jejunostomy after esophagectomy: a meta-analysis.
     Dis Esophagus. 2023;36:doac105.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum